Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05865470 · ClinicalTrials.gov registry record · Phase 1

Age-dependent Effects of Smoked and Oral Delta-9-THC

A Phase 1 study of Pain and Abuse, Drug, sponsored by University of California, Los Angeles.

Recruiting
Registry status
Phase 1
Development phase
103
Enrollment target
1
Study location

NCT05865470 is a Phase 1 study of Pain and Abuse, Drug that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 103 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05865470, a Phase 1 study of Pain and Abuse, Drug, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
Phase 1
Development phase
103 participants
Enrollment target
1
Study location

Study Summary

This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.

Interventions

  • DRUG Oral Placebo
  • DRUG Dronabinol
  • DRUG Cannabis
  • DRUG Smoked Placebo

Study Locations (1)

California

  • UCLA Center for Cannabis and Cannabinoids - Los Angeles

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2025-04-30
Est. Completion 2029-10-15
Phase Phase 1

What the Registry Record Tells You About NCT05865470

The ClinicalTrials.gov registry entry for NCT05865470 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (66% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Oral Placebo is the first listed.

NCT05865470 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05865470 about?

NCT05865470 is a clinical study titled "Age-dependent Effects of Smoked and Oral Delta-9-THC". This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.

What is the current status of trial NCT05865470?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 103 participants. The study started on 2025-04-30. Estimated completion is 2029-10-15.

What conditions does trial NCT05865470 study?

This clinical trial studies the following conditions: Pain, Abuse, Drug, Intoxication; Cannabinoids.

What interventions are being tested in trial NCT05865470?

The interventions under investigation include: Oral Placebo (DRUG), Dronabinol (DRUG), Cannabis (DRUG), Smoked Placebo (DRUG).

Who is sponsoring clinical trial NCT05865470?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05865470 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.